Bristol, United Kingdom

Paolo Madeddu

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Reneuron, Inc.. Active years: 2015-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paolo Madeddu. Retrieved from https://idiyas.com/inventor/paolo-madeddu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Paolo Madeddu

Introduction

Paolo Madeddu is a prominent inventor based in Bristol, GB, known for his significant contributions to the field of medical science. With a focus on innovative treatments for peripheral arterial disease, he has developed groundbreaking solutions that utilize neural stem cells.

Latest Patents

Madeddu holds two notable patents, both centered around the treatment of limb ischemia. His inventions involve the use of neural stem cells in the manufacture of a medicament aimed at treating patients suffering from peripheral arterial disease. These inventions are particularly suited for addressing conditions such as limb ischemia and Buerger's disease.

Career Highlights

Throughout his career, Madeddu has made substantial advancements in medical research and innovation. His work has garnered attention for its potential to improve the quality of life for patients with severe vascular conditions.

Collaborations

Madeddu collaborates with esteemed colleagues, including John Sinden and Erik Miljan, who contribute to the research and development of his innovative treatments.

Conclusion

Paolo Madeddu's work exemplifies the intersection of innovation and medical science, showcasing the potential of neural stem cells in treating critical health issues. His contributions continue to pave the way for advancements in the treatment of peripheral arterial disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…